Supply Chain and Business Continuity Risks from Infectious Diseases such as COVID-19
First written in FY2020. 4 of 14 entries say "Reframed", first in FY2021. Latest entry: FY2026.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2026RestatedAnnual report
「The Company has been developing a crisis-management framework and taking measures in preparation for emergencies. However, if a large-scale natural disaster such as an earthquake or typhoon occurs, or if an infectious disease occurs and spreads on a scale far exceeding expectations, the resulting direct and indirect effects could affect the Company's operating results and financial position through the suspension or closure of production facilities operated by business partners, shipment restrictions, shortages of related components and the cancellation of new-business development activities due to restrictions on going outdoors.」
The Company has reconfirmed business continuity risks arising from natural disasters and infectious diseases, including the suspension of business partners' production, component shortages, shipment restrictions and the cancellation of new-business development activities. - FY2025RestatedAnnual report
「The Company has been developing a crisis-management framework and taking measures in preparation for emergencies. However, if a large-scale natural disaster such as an earthquake or typhoon occurs, or if an infectious disease occurs and spreads on a scale far exceeding expectations,」
The Company has reconfirmed business continuity risks arising from natural disasters and infectious diseases, including the suspension of business partners' production, component shortages, shipment restrictions and the cancellation of new-business development activities. - FY2023-Q3MaterialisedAnnual report
「In the nano/micro-technology-related business, sales, which had been expected to improve from the second half onward, remained sluggish, particularly in the industrial equipment field and inkjet-related components, because production of products ordered by the company was adjusted amid the economic slowdown caused by China’s lockdowns and the impact of semiconductor shortages affecting products made by some customers.」
China's lockdowns and semiconductor shortages have resulted in production adjustments for ordered products and sluggish growth in fields such as industrial equipment. - FY2023-Q2MaterialisedAnnual report
「The nano/microtechnology-related business was affected by production adjustments for products ordered by the Company due to semiconductor shortages affecting some customers' products, as well as by China's lockdowns. As a result, the Company's order volume temporarily declined sharply, production became unstable and production efficiency fell.」
Semiconductor shortages and China's lockdowns actually resulted in production adjustments, a temporary sharp decline in order volume, unstable production and lower production efficiency. - FY2023-Q1WorsenedAnnual report
「The global economy during the cumulative first-quarter period under review faced significant downside risks as Russia's prolonged invasion of Ukraine and the G7 countries' economic sanctions against Russia continued, driving up prices of crude oil, natural gas, mineral resources and grains, while supply chain disruptions accompanied urban lockdowns under China's zero-COVID policy.」
Supply chain disruptions associated with urban lockdowns under China's zero-COVID policy were newly described in specific terms, heightening supply-chain risks arising from infectious diseases and government policy. - FY2022RestatedAnnual report
「Regarding the strengthening of sales capabilities for new-business development, the number of customers that can be visited is increasing and business has recovered year on year as the Company makes use of Web-based meetings. However, activities to develop new customers and new products struggled amid the spread of the Omicron variant of COVID-19.」
Sales activities recovered year on year through the use of Web-based meetings and an increase in the number of customers that could be visited, while efforts to develop new customers and new products struggled due to the spread of the Omicron variant. - FY2022-Q3ReframedAnnual report
「Regarding the strengthening of sales capabilities for new-business development, the number of customers that can be visited is increasing and business has recovered year on year as the Company makes use of Web-based meetings. However, with the spread of the Omicron variant of COVID-19, activities to develop new customers and new products remain uncertain.」
The Company reports the use of Web-based meetings, an increase in the number of customers it can visit and a year-on-year recovery, while activities to develop new customers and new products remain uncertain due to the spread of the Omicron variant, presenting both recovery and sales constraints. - FY2022-Q2ReframedAnnual report
「Regarding the strengthening of sales capabilities for new-business development, the Company is making use of Web-based meetings, the number of customers it can visit is increasing and revenue is gradually rising. However, amid concerns over a further increase in COVID-19 infections, activities to develop new customers and new products remain uncertain.」
The Company reports the use of Web-based meetings, an increase in the number of customers it can visit and higher revenue, while activities to develop new customers and new products remain uncertain because of concerns over a resurgence of infections, presenting both recovery and constraints. - FY2022-Q1ReframedAnnual report
「Regarding the strengthening of sales capabilities for new-business development, the number of customers that can be visited is increasing as the Company makes use of Web-based meetings. However, with infections increasing in major metropolitan areas, activities to develop new customers and new products remain uncertain.」
While the Company is making use of Web-based meetings and the number of customers it can visit is increasing, activities to develop new customers and new products remain uncertain due to the increase in infections in major metropolitan areas, presenting both recovery and sales constraints. - FY2021ReframedAnnual report
「The Company was significantly affected in production and sales by reduced shipments resulting from the temporary shutdown of business partners' operations and production adjustments, as well as major restrictions on new-business development activities due to restrictions on going outdoors. Subsequently, overseas economies, including China and the United States, entered a recovery trend after reaching a trough in the cumulative first-quarter period.」
While the shutdown of business partners' operations, reduced shipments and sales restrictions caused by infectious diseases actually occurred, the subsequent recovery trend in overseas economies was also described, changing the risk assessment to encompass both the initial sharp deterioration and the subsequent recovery. - FY2021-Q3WorsenedAnnual report
「Regarding the strengthening of sales capabilities for new-business development, the Company had begun to see an increase in the number of customers it could visit while making use of Web-based meetings. However, with the reissuance of the state of emergency declaration, in-person activities to develop new customers are becoming increasingly difficult.」
While the Company has made use of Web-based meetings and the number of customers it can visit has increased, in-person activities to develop new customers have again become more difficult following the reissuance of the state of emergency declaration. - FY2021-Q2MitigatedAnnual report
「The Company was also significantly affected in production and sales from the beginning of the fiscal year under review by the spread of COVID-19. However, toward the end of the second quarter, signs of a recovery in demand began to emerge, particularly in the nano/microtechnology-related fields.」
The impact of the spread of COVID-19 on production and sales has continued, but signs of a recovery in demand, particularly in the nano/micro fields, emerged toward the end of the second quarter, partially mitigating the impact. - FY2021-Q1MaterialisedAnnual report
「The company has also been significantly affected in production and sales, as temporary shutdowns and production adjustments at business partners reduced shipments, while restrictions on going out severely limited new-business development, making it difficult to secure the sales originally planned.」
The shutdown of business partners' operations, reduced shipments and sales restrictions anticipated in the previous fiscal year as infectious-disease risks actually occurred, affecting production, sales activities and efforts to secure revenue. - FY2020First statedAnnual report
「The Company has been developing a crisis-management framework and taking measures in preparation for emergencies. However, if a large-scale natural disaster such as an earthquake or typhoon occurs, or if an infectious disease such as novel influenza or COVID-19 occurs and spreads on a scale far exceeding expectations, the resulting direct and indirect effects could affect the Company's operating results and financial position through shortages of related components caused by the suspension or closure of production facilities operated by business partners and shipment restrictions, as well as the cancellation of new-business development activities due to restrictions on going outdoors.」
Natural disasters and infectious diseases are explicitly identified for the first time as risks that could affect operating results and financial position through the shutdown of business partners' production facilities, component shortages, shipment restrictions and the cancellation of new-business development activities. The global spread of COVID-19 and its impact on the supply chain had already been described as part of the operating environment for the fiscal year under review.